Medicines Patent Pool (original) (raw)

About DBpedia

Le Medicines Patent Pool (MPP) est une organisation internationale soutenue par les Nations unies fondée en juillet 2010 basée à Genève, en Suisse. Son objectif est de réduire les prix des médicaments contre le VIH, la tuberculose et l'hépatite C, et de faciliter le développement de traitements anti-VIH, grâce à l'octroi de licences de brevets dans les pays à revenu faible ou intermédiaire.

Property Value
dbo:abstract Le Medicines Patent Pool (MPP) est une organisation internationale soutenue par les Nations unies fondée en juillet 2010 basée à Genève, en Suisse. Son objectif est de réduire les prix des médicaments contre le VIH, la tuberculose et l'hépatite C, et de faciliter le développement de traitements anti-VIH, grâce à l'octroi de licences de brevets dans les pays à revenu faible ou intermédiaire. (fr) The Medicines Patent Pool (MPP) is a Unitaid-backed international organisation founded in July 2010, based in Geneva, Switzerland. Its public health driven business model aims to lower the prices of HIV, tuberculosis and hepatitis C medicines and facilitate the development of better-adapted HIV treatments through voluntary licensing and patent pooling. Its goal is to improve access to affordable and appropriate HIV, hepatitis C and tuberculosis medicines in low- and middle-income countries (LMIC). In May 2020, the MPP become an implementing partner of the WHO's Covid-19 Technology Access Pool (C-TAP). Peer-reviewed economics research find that the MPP substantially increased generic drug supplies, especially in countries with stronger patent protection; positive spillover effect to upstream innovation is found in clinical trials and drug product approvals in MPP-related drugs. A related study found that there is an immediate and large increase in licensing of a life-saving drug in low- and middle-income countries when the patent is included in the MPP. (en) 藥品專利池(英語:Medicines Patent Pool,縮寫:MPP)是一個由國際藥品採購機制支持的國際公共衛生組織,成立於2010年7月,總部位於瑞士日內瓦。其設立的目標是要為中低收入國家,提高獲得救命藥品的機會。藥品專利池通過商業模式,與民間組織、國際組織、各國政府、工業機構、患者團體及其他利益攸關方共同合作,優先開發及提供生產藥品所需的許可,匯集知識產權,鼓勵生產仿製藥物及開發新配方,使中低收入國家能夠以負擔得起的價格,獲得防治愛滋病、結核病、丙型肝炎及2019冠状病毒病等疾病的藥品。國際藥品採購機制是藥品專利池的創建機構及主要出資者。 (zh)
dbo:wikiPageExternalLink https://medicinespatentpool.org
dbo:wikiPageID 39791125 (xsd:integer)
dbo:wikiPageLength 16598 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID 1123651734 (xsd:integer)
dbo:wikiPageWikiLink dbr:Patent_pool dbr:Boehringer_Ingelheim dbr:Johns_Hopkins_University dbr:Pfizer dbr:ViiV_Healthcare dbr:Proprietary_drug dbr:Ellen_'t_Hoen dbr:Epidemiology_of_HIV/AIDS dbr:Geneva dbr:Gilead_Sciences dbr:Molnupiravir dbr:Médecins_Sans_Frontières dbr:Malaria dbr:Bristol-Myers_Squibb dbr:COVAX dbr:Tuberculosis dbr:Doha_Declaration dbr:Abacavir dbr:AbbVie dbc:International_medical_and_health_organizations dbr:PF-07321332 dbr:Marie-Paule_Kieny dbr:HIV/AIDS dbr:Janssen_Pharmaceutica dbc:HIV/AIDS_organizations dbc:Tuberculosis_organizations dbc:International_organisations_based_in_Switzerland dbc:Malaria_organizations dbr:Merck_Sharp_and_Dohme dbr:Merck_&_Co. dbr:Unitaid dbr:Executive_Board dbr:Licensing_Executives_Society dbr:F._Hoffmann-La_Roche dbr:US_National_Institutes_of_Health
dbp:wikiPageUsesTemplate dbt:Citation_needed dbt:Reflist dbt:Rp dbt:Short_description dbt:Use_dmy_dates
dct:subject dbc:International_medical_and_health_organizations dbc:HIV/AIDS_organizations dbc:Tuberculosis_organizations dbc:International_organisations_based_in_Switzerland dbc:Malaria_organizations
gold:hypernym dbr:Organisation
rdf:type yago:WikicatMalariaOrganizations yago:WikicatTuberculosisOrganizations yago:Abstraction100002137 yago:Group100031264 yago:Organization108008335 yago:WikicatHIV/AIDSOrganizations yago:WikicatInternationalNon-profitOrganizations yago:YagoLegalActor yago:YagoLegalActorGeo yago:YagoPermanentlyLocatedEntity dbo:Organisation yago:SocialGroup107950920
rdfs:comment Le Medicines Patent Pool (MPP) est une organisation internationale soutenue par les Nations unies fondée en juillet 2010 basée à Genève, en Suisse. Son objectif est de réduire les prix des médicaments contre le VIH, la tuberculose et l'hépatite C, et de faciliter le développement de traitements anti-VIH, grâce à l'octroi de licences de brevets dans les pays à revenu faible ou intermédiaire. (fr) 藥品專利池(英語:Medicines Patent Pool,縮寫:MPP)是一個由國際藥品採購機制支持的國際公共衛生組織,成立於2010年7月,總部位於瑞士日內瓦。其設立的目標是要為中低收入國家,提高獲得救命藥品的機會。藥品專利池通過商業模式,與民間組織、國際組織、各國政府、工業機構、患者團體及其他利益攸關方共同合作,優先開發及提供生產藥品所需的許可,匯集知識產權,鼓勵生產仿製藥物及開發新配方,使中低收入國家能夠以負擔得起的價格,獲得防治愛滋病、結核病、丙型肝炎及2019冠状病毒病等疾病的藥品。國際藥品採購機制是藥品專利池的創建機構及主要出資者。 (zh) The Medicines Patent Pool (MPP) is a Unitaid-backed international organisation founded in July 2010, based in Geneva, Switzerland. Its public health driven business model aims to lower the prices of HIV, tuberculosis and hepatitis C medicines and facilitate the development of better-adapted HIV treatments through voluntary licensing and patent pooling. Its goal is to improve access to affordable and appropriate HIV, hepatitis C and tuberculosis medicines in low- and middle-income countries (LMIC). In May 2020, the MPP become an implementing partner of the WHO's Covid-19 Technology Access Pool (C-TAP). (en)
rdfs:label Medicines Patent Pool (fr) Medicines Patent Pool (en) 藥品專利池 (zh)
owl:sameAs freebase:Medicines Patent Pool yago-res:Medicines Patent Pool wikidata:Medicines Patent Pool dbpedia-fr:Medicines Patent Pool dbpedia-zh:Medicines Patent Pool https://global.dbpedia.org/id/fuwS
prov:wasDerivedFrom wikipedia-en:Medicines_Patent_Pool?oldid=1123651734&ns=0
foaf:isPrimaryTopicOf wikipedia-en:Medicines_Patent_Pool
is dbo:wikiPageDisambiguates of dbr:MPP
is dbo:wikiPageWikiLink of dbr:Proprietary_drug dbr:Ellen_'t_Hoen dbr:Efavirenz/emtricitabine/tenofovir dbr:Molnupiravir dbr:Multidrug-resistant_tuberculosis dbr:COVAX dbr:Nirmatrelvir dbr:Marie-Paule_Kieny dbr:Cost_of_HIV_treatment dbr:MPP dbr:Pharmaceutical_innovations dbr:Responses_to_the_COVID-19_pandemic_in_November_2021 dbr:Unitaid dbr:Technology_transfer
is foaf:primaryTopic of wikipedia-en:Medicines_Patent_Pool